Literature DB >> 6490810

Detection of encapsulation in Staphylococcus aureus by use of antiserum agar.

T E West, M A Apicella.   

Abstract

We examined an antiserum agar method to study its reliability in screening Staphylococcus aureus strains for capsule production. The encapsulated S. aureus Smith diffuse strain was compared with its nonencapsulated variant, Smith compact, in CCY medium containing 0.5% NaCl and 5.0% Smith diffuse rabbit antiserum. A halo was visible surrounding colonies of the Smith diffuse strain but not the Smith compact strain. On this same medium, the protein A-producing Cowan I strain possessed a halo that was visible on photographs. Single high-salt medium is known to inhibit protein A production, halo formation by the strains was also compared in 7.5% NaCl medium. The halo surrounding the Cowan I strain was not present when the salt content of the medium was increased. In contrast, the halo surrounding the Smith diffuse strain persisted in the 7.5% NaCl medium. By use of this medium, the antiserum agar technique may be valuable for the identification of encapsulated staphylococci without appreciable interference from protein A.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490810      PMCID: PMC271272          DOI: 10.1128/jcm.20.2.141-144.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Agglutinability of pyogenic staphylococci at various conditions.

Authors:  P OEDING
Journal:  Acta Pathol Microbiol Scand       Date:  1957

2.  Characteristics of coagulase positive and coagulase negative staphylococci in serum-soft agar.

Authors:  R A FINKELSTEIN; S E SULKIN
Journal:  J Bacteriol       Date:  1958-03       Impact factor: 3.490

3.  Formation of extracellular protein A by Staphylococcus aureus.

Authors:  J Movitz
Journal:  Eur J Biochem       Date:  1976-09

Review 4.  Use of staphylococcal protein A as an immunological reagent.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

5.  Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  M W Bradshaw; R Schneerson; J C Parke; J B Robbins
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

6.  Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination.

Authors:  D E Craven; C E Frasch; J B Robbins; H A Feldman
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

7.  Evaluation of the antiserum agar method for the serogroup identification of Neisseria meningitidis.

Authors:  F E Ashton; A Ryan; B B Diena; C E Frasch
Journal:  Can J Microbiol       Date:  1979-06       Impact factor: 2.419

8.  A comparison of the serum agar grouping and slide agglutination methods for the identification of Neisseria meningitidis strains.

Authors:  P Kuzemenská; V Burian; C E Frasch; E Svandová
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

9.  An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.

Authors:  R Schneerson; M Bradshaw; J K Whisnant; R L Myerowitz; J C Parke; J B Robbins
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

10.  Factors relating to the virulence of staphylococci. I. Comparative studies on two colonial variants.

Authors:  M G KOENIG
Journal:  Yale J Biol Med       Date:  1962-06
View more
  2 in total

1.  Antiserum agar method for identification of Smith type exopolysaccharides in clinical isolates of Staphylococcus aureus.

Authors:  T E West; M E West; J M Mylotte
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

2.  Staphylococcal peritonitis in patients on continuous peritoneal dialysis.

Authors:  T E West; J J Walshe; C P Krol; D Amsterdam
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.